As of Feb 05
| -2.22 / -8.72%|
The 5 analysts offering 12-month price forecasts for NewLink Genetics Corp have a median target of 62.00, with a high estimate of 63.00 and a low estimate of 45.00. The median estimate represents a +166.90% increase from the last price of 23.23.
The current consensus among 5 polled investment analysts is to Buy stock in NewLink Genetics Corp. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.